Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
The American Journal of Physiology|December 1, 1995
Effect of L-NAME on pressure-flow relationships in isolated rabbit lungs: role of red blood cellsR S Sprague, A H Stephenson, R A Dimmitt, et al.
Cold Spring Harbor Molecular Case Studies|March 25, 2018
Identification of novel MECOM gene fusion and personalized therapeutic targets through integrative clinical sequencing in secondary acute myeloid leukemia in a patient with severe congenital neutropenia: a case report and literature reviewJames A Connelly, Rajen J Mody, Yi-Mi Wu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 2, 2009
Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progressionBo Han, Rohit Mehra, Robert J Lonigro, et al.
Cancer Research|February 5, 2008
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancerBharathi Laxman, David S Morris, Jianjun Yu, et al.
Neoplasia (New York, N.Y.)|December 2, 2011
Detection of somatic copy number alterations in cancer using targeted exome capture sequencingRobert J Lonigro, Catherine S Grasso, Dan R Robinson, et al.
Cancer Research|June 17, 2011
TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancersRam-Shankar Mani, Matthew K Iyer, Qi Cao, et al.
Cancer Research|April 23, 2009
Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancerRou Wang, David S Morris, Scott A Tomlins, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 30, 2007
Surgical patient outcomes after the increased use of bilateral lung transplantationAndrew C Chang, Kevin M Chan, Robert J Lonigro, et al.
European Urology|May 20, 2015
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk AssessmentScott A Tomlins, John R Day, Robert J Lonigro, et al.
JCO Precision Oncology|August 25, 2020
Integration of Germline Pharmacogenetics Into a Tumor Sequencing ProgramDaniel L Hertz, Andrew Glatz, Amy L Pasternak, et al.
Pageof 11